This IPO was a brick. Not going up till it makes a profit. Super spend on marketing with nothing to show for it. The partners should also be sponsoring the use of the product.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025